RecruitingNCT05489549

Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR Carriers

Studying Amyloidosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Texas Southwestern Medical Center
Principal Investigator
Justin L Grodin, MD MPH
UT Southwestern
Enrollment
500 enrolled
Eligibility
30-80 years · All sexes
Timeline
2022 – 2027

Study locations (3)

Collaborators

The Cleveland Clinic · Columbia University · The University of Texas at Arlington · National Heart, Lung, and Blood Institute (NHLBI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05489549 on ClinicalTrials.gov

Other trials for Amyloidosis

Additional recruiting or active studies for the same condition.

See all trials for Amyloidosis →

← Back to all trials